Medical Doctor Program year 2024 Reported 2019–2024 Source: CMS Open Payments, 2026 publication

David Allen

Urology Athens, GA Medical Doctor

NPI 1669471496 CMS profile 302003

120 Trinity Pl, Athens, GA 30607

Open in the dashboard

General payments

$2,620

110 records reported · program years 2019–2024

Research payments

$0

Paid to them · None reported · program years 2019–2024

Ownership & investment interest

$0

None reported

Through program year 2024, David Allen of Athens, GA is reported in the CMS Open Payments database as having received $2,620 across 110 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 49th percentile of Urology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

6 rows
Year Kind Relative to this record's peak year Amount Records
2024 General $17 1
2023 General $19 1
2022 General $484 21
2021 General $487 27
2020 General $323 23
2019 General $1,290 37

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • David Allen
  • Urology median
  • Middle half of Urology
  • National median

In program year 2025, general payments to David Allen were reported at $0. Among 9,461 Urology profiles paid that year, the median was $629 and the middle half received between $190 and $1,620.

Show as a table
Year David Allen Urology median Middle half National median
2019 $1,290 $480 $147–$1,201 $163
2020 $323 $246 $87–$645 $114
2021 $487 $358 $111–$1,000 $132
2022 $484 $476 $143–$1,263 $149
2023 $19 $560 $168–$1,461 $160
2024 $17 $563 $170–$1,464 $164
2025 $0 $629 $190–$1,620 $169

Breakdown

Who paid General payments · program years 2019–2024
  1. Coloplast Corp $769 7 payments
  2. Astellas Pharma US Inc $304 17 payments
  3. Myovant Sciences Inc. $234 11 payments
  4. Bayer HealthCare Pharmaceuticals Inc. $191 11 payments
  5. Pfizer Inc. $183 7 payments
  6. Myriad Genetic Laboratories, Inc. $112 6 payments
  7. Janssen Biotech, Inc. $100 6 payments
  8. TOLMAR Pharmaceuticals, Inc. $89 4 payments
  9. Dendreon Pharmaceuticals LLC $87 3 payments
  10. AbbVie, Inc. $78 5 payments
  11. Other $473 33 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2024
  1. Food and Beverage $1,971 98 payments
  2. Education $649 12 payments
Products named General payments · program years 2019–2024
  1. TITAN $719 4 payments
  2. XTANDI $350 20 payments
  3. ORGOVYX $234 11 payments
  4. MYRBETRIQ $182 14 payments
  5. Nubeqa $165 9 payments
  6. ERLEADA $145 9 payments
  7. Prolaris $90 5 payments
  8. ELIGARD $89 4 payments
  9. PROVENGE $87 3 payments
  10. LUPRON DEPOT $78 5 payments
  11. Other $603 41 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

110 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Urology in Georgia

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2024

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record